RI 2026 S2666: State Affairs and Government - The Rhode Island Medicaid Reform Act of 2008

Plain-English Summary

This legislation mandates that the Rhode Island Medicaid program provide coverage for specific fertility services starting January 1, 2027. The bill requires coverage for fertility diagnostic care, standard fertility preservation (such as freezing eggs or sperm) for medical reasons, and treatments including ovulation medications and intrauterine insemination (IUI). It broadly defines infertility to include individuals and couples who cannot conceive due to medical history, age, disability, or a lack of necessary gametes, ensuring access for LGBTQ+ individuals and single people. It also requires the state to study the feasibility and cost of covering In Vitro Fertilization (IVF).

For younger readers

This new law helps people who want to have a baby but are having trouble doing so. Starting in 2027, the government health insurance called Medicaid will pay for doctors to do tests to see why someone cannot get pregnant. It will also pay for medicines and a procedure called IUI, which helps the sperm meet the egg to start a pregnancy. The law also helps people save their eggs or seeds if they need medicine that might stop them from having babies later. It makes sure everyone is treated fairly, no matter who they are.

Who & Where It Applies

Impacted groups

Medicaid recipientsIndividuals experiencing infertilityLGBTQ+ communityFertility clinics and specialistsTaxpayers

Impacted communities

All

Constitutional & Fiscal Check

None Likely

Estimated cost

Amount unknown

Estimated revenue

None

Bill Analysis

Both viewpoints

For Progressives

Promotes socioeconomic equity by providing expensive fertility treatments to low-income individuals on Medicaid who historically could not afford these services.
Ensures inclusivity for the LGBTQ+ community and single individuals by defining infertility to include the inability to establish pregnancy due to a lack of necessary gametes.
Protects the reproductive rights of individuals with disabilities by explicitly prohibiting coverage exclusions based on disability or prior medical history.
Fails to provide immediate full coverage for In Vitro Fertilization (IVF), the most effective fertility treatment, instead relegating it to a study and conditional coverage only if IUI is counter-indicated.
Includes a significant delay in implementation, as the coverage mandates do not go into effect until January 1, 2027, leaving current patients without support for several years.
Limits intrauterine insemination (IUI) coverage to six cycles, which may not be sufficient for all patients to achieve a successful pregnancy.

For Conservatives

Encourages the formation and growth of families, aligning with traditional values regarding procreation and child-rearing.
Demonstrates fiscal restraint by requiring a feasibility study and cost analysis before committing to the funding of expensive In Vitro Fertilization (IVF) procedures.
Prioritizes less invasive and lower-cost treatments (medication and IUI) over high-cost surgical interventions, potentially controlling taxpayer expenditures.
Expands government entitlement programs by adding costly services to Medicaid, which will increase the financial burden on taxpayers.
Redefines infertility to include social infertility (lack of gametes), effectively mandating taxpayer funding for non-traditional family structures and lifestyle choices.
Mandates coverage for fertility preservation (freezing genetic material) for up to five years or age 30, creating a long-term financial obligation for the state.

Votes

Loading votes...

Full Bill Text

Changes to existing Rhode Island law · 63 additions

SECTION 1. Chapter 42-12.4 of the General Laws entitled "The Rhode Island Medicaid Reform Act of 2008" is hereby amended by adding thereto the following section: 42-12.4-10. Fertility.

(a) Definitions: As used in this section, the following words or terms shall have the following meanings unless the context shall clearly indicate another or different meaning or intent:

(1) "Fertility diagnostic care" means counseling, products, medications, procedures, genetic testing, and services intended to provide information about an individual's fertility, including laboratory assessments and imaging studies.

(2) “Infertility” means:

(i) The presence of a condition recognized by a health care provider that impacts an individual’s ability to establish a pregnancy or to carry a pregnancy based on an individual’s medical, sexual, and reproductive history; age; physical findings; diagnostic testing; or any combination of these factors. This includes infertility arising from disabilities or from medical treatments or conditions associated with disability;

(ii) An individual’s inability to establish a pregnancy because the individual or the individual and the individual’s partner do not have the necessary gametes to establish a pregnancy; or

(iii) An individual’s inability to establish a pregnancy or to carry a pregnancy to live birth after twelve (12) months of unprotected sexual intercourse when the individual and the individual’s partner have the necessary gametes to establish a pregnancy. Pregnancy loss does not restart the twelve-month period.

(3) "Intrauterine insemination" means a procedure that places sperm directly into an individual's uterus at the time of ovulation to increase the chances of fertilization.

(4) “Standard fertility preservation services” means counseling, products, medications, procedures, genetic testing, and services intended to preserve fertility, consistent with established medical practice and professional guidelines published by the American Society for Reproductive Medicine or the American Society for Clinical Oncology for an individual who has a medical or genetic condition, including conditions related to disability or chronic illness, or who is expected to receive medical treatment that has a side effect or possible side effect of a risk to an individual’s fertility and includes, but is not limited to expenses related to evaluation, laboratory assessments, medications, and treatment, as well as the procurement and cryopreservation of gametes, embryos, and reproductive material and storage.

(5) “Department” means the executive office of health and human services (EOHHS).

(b) Beginning January 1, 2027, the department shall provide Medicaid coverage for:

(1) Fertility diagnostic care;

(2) Standard fertility preservation including, but not limited to, storage from the time of cryopreservation provided that coverage for such storage shall extend until the individual reaches the age of thirty (30), or for a period five (5) years, whichever is later. Storage may be offered for a longer period of time; and

(3) Treatment of infertility including any medically necessary ovulation-enhancing medications and medical services related to prescribing and monitoring the use of the ovulation- enhancing medications for at least three (3) cycles of ovulation-enhancing medication treatment; and at least six (6) cycles of intrauterine insemination. In the event that ovulation-enhancing medication treatment administered with intention to prepare for intrauterine insemination results in an ovulation response that counter-indicates intrauterine insemination, coverage for invitro fertilization and embryo transfer as recommended by the treating physician.

(1) Impose a waiting period;

(2) Use any prior diagnosis, an individual’s disability, or prior fertility treatment as a basis for excluding, limiting, or otherwise restricting the availability of coverage required by this section;

(3) Impose any limitations on coverage for any fertility services based on an individual’s use of donor gametes; and

(4) Impose different limitations on coverage for, provide different benefits to, or impose different requirements on a class of persons on account of their age, ancestry, color, disability, ethnicity, gender identity, genetic information, marital status, national origin, race, religion, sex, or sexual orientation.

(d) On or before January 1, 2027, the department shall submit a report to the speaker of the house and president of the senate after consulting with the centers for Medicare & Medicaid Services on whether in vitro fertilization (IVF) is a medically reasonable and necessary procedure under federal law, possible methods for covering IVF as a Medicaid covered benefit for both fee- for-service and managed care organizations, including any potentially applicable waiver authorities, and the amount of money that would need to be allocated to federal and local funds for such coverage.

(e) The provisions of this section shall apply to Medicaid state plans issued or renewed on or after January 1, 2027.

SECTION 2. This act shall take effect upon passage.